Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SSA Standard Should Focus On Claim Truthfulness, CHPA Says

This article was originally published in The Tan Sheet

Executive Summary

The "significant scientific agreement" standard for dietary supplement and conventional food health claims should focus on the truthfulness of proposed health claims rather than the "validity" of the nutrient/disease relationship, the Consumer Healthcare Products Association asserts in Feb. 22 comments.

You may also be interested in...



Supplement/Disease Claim Continuum Suggested By CHPA

FDA acceptance of disease-treatment health claims and subsequent revision of the term "nutritive value" to reflect a dietary supplement ingredient's ability to restore normal/proper function is urged by the Consumer Healthcare Products Association.

Supplement/Disease Claim Continuum Suggested By CHPA

FDA acceptance of disease-treatment health claims and subsequent revision of the term "nutritive value" to reflect a dietary supplement ingredient's ability to restore normal/proper function is urged by the Consumer Healthcare Products Association.

Supplement/Disease Claim Continuum Suggested By CHPA

FDA acceptance of disease-treatment health claims and subsequent revision of the term "nutritive value" to reflect a dietary supplement ingredient's ability to restore normal/proper function is urged by the Consumer Healthcare Products Association.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel